Wordt geladen...

Docetaxel-Related Toxicity in Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer

BACKGROUND: Docetaxel plus androgen deprivation therapy (ADT) offers a survival benefit in metastatic hormone-sensitive prostate cancer (mHSPC). However, one trial evaluating docetaxel in mHSPC (GETUG-AFU15) showed unexpected toxicity; raising concerns that docetaxel may carry increased toxicity whe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Med Oncol
Hoofdauteurs: Schweizer, Michael T., Gulati, Roman, Mostaghel, Elahe A., Nelson, Peter S., Montgomery, R. Bruce, Yu, Evan Y., Cheng, Heather H.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5298886/
https://ncbi.nlm.nih.gov/pubmed/27300548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-016-0793-1
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!